MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Medtech in a Minute: Trump's Pick for FDA, Stryker's Huge Deal, and More Medtronic-Axonics Drama

Pressed for time? Here's the medtech news you need most, in one minute or less.

Trump Taps Hahn for FDA Head

President Trump's pick for FDA commissioner won support from AdvaMed. Stephen Hahn, a chief medical executive at the MD Anderson Cancer Center, has authored 220 peer-reviewed original research articles and is known for taking an evidence-based approach to current healthcare challenges. The nomination comes nearly eight months after Scott Gottlieb vacated the position.

 

Stryker Has the 'Wright' Idea

Stryker has agreed to pay $4 billion for Wright Medical, which would significantly strengthen the company's trauma and extremities business. But the deal could trigger anti-trust concerns, result in some revenue dis-synergies, and potentially distract from Stryker's ongoing integration of K2M.

An Unexpected Turn in the SNM Market Battle

The battle between Medtronic and Axonics over the sacral neuromodulation (SNM) market took an unexpected turn as the incumbent slapped its challenger with a patent infringement lawsuit that could take years to play out. Medtronic says it is simply protecting its intellectual property, but Axonics sees it as an attempt to suppress competition.

 

Filed Under
500 characters remaining